Abstract: A tubular or non-tubular implant or prosthetic is provided to prevent or mitigate infection when implanted into a living body. The implant or prosthetic includes a textile layer comprising a plurality of interstices and/or pores and defining an interfacing surface and an opposing surface. The implant or prosthetic also includes a sealing layer comprising a non-porous, non-organic polymer adhered to the interfacing surface. The non-porous, non-organic polymer is formed of a material configured to prevent transmission or migration of bacteria through the sealing layer. The implant or prosthetic may also be configured to be anti-wetting and therefore provide for easier explantation from the body, to protect the textile layer from damage from electrocautery energy, and also to prevent leakage as well as transmural communication or migration through the graft body or wall while still allowing ingrowth of tissue along at least a portion of implant or prosthetic for secured anchoring.

Abstract: Textile-based implant or prosthetic tubular or non-tubular products are provided that require two materials, textile and an impermeable, non-organic hydrophobic or super hydrophobic material, that when constructed into a graft product of the present invention produce three distinct zones. The resulting self-sealing implant or prosthetic product is super anti-wetting and therefore provides for easier explantation from the body. Explantation is further improved by the resistance of one surface to electrosurgical energy such as electrocautery. The implant or prosthetic products also prevent leakage as well as transmural communication or migration through the graft body or wall while still allowing ingrowth of tissue along at least a portion of one surface of the implant or prosthetic for secured anchoring.

Abstract: A stent scaffold combined with amniotic tissue provides for a biocompatible stent that has improved biocompatibility and hemocompatibility. The amnion tissue can be variously modified or unmodified form of amnion tissue such as non-cryo amnion tissue, solubilized amnion tissue, amnion tissue fabric, chemically modified amnion tissue, amnion tissue treated with radiation, amnion tissue treated with heat, or a combination thereof. Materials such as polymer, placental tissue, pericardium tissue, small intestine submucosa can be used in combination with the amnion tissue. The amnion tissue can be attached to the inside, the outside, both inside and outside, or complete encapsulation of the stent scaffold. In some embodiments, at least part of the covering or lining comprises a plurality of layers of amnion tissue. The method of making the biocompatible stent and its delivery and deployment are also discussed.

Abstract: A stent scaffold combined with amniotic tissue provides for a biocompatible stent that has improved biocompatibility and hemocompatibility. The amnion tissue can be variously modified or unmodified form of amnion tissue such as non-cryo amnion tissue, solubilized amnion tissue, amnion tissue fabric, chemically modified amnion tissue, amnion tissue treated with radiation, amnion tissue treated with heat, or a combination thereof. Materials such as polymer, placental tissue, pericardium tissue, small intestine submucosa can be used in combination with the amnion tissue. The amnion tissue can be attached to the inside, the outside, both inside and outside, or complete encapsulation of the stent scaffold. In some embodiments, at least part of the covering or lining comprises a plurality of layers of amnion tissue. The method of making the biocompatible stent and its delivery and deployment are also discussed.

Abstract: A stent scaffold combined with amniotic tissue provides for a biocompatible stent that has improved biocompatibility and hemocompatibility. The amnion tissue can be variously modified or unmodified form of amnion tissue such as non-cryo amnion tissue, solubilized amnion tissue, amnion tissue fabric, chemically modified amnion tissue, amnion tissue treated with radiation, amnion tissue treated with heat, or a combination thereof. Materials such as polymer, placental tissue, pericardium tissue, small intestine submucosa can be used in combination with the amnion tissue. The amnion tissue can be attached to the inside, the outside, both inside and outside, or complete encapsulation of the stent scaffold. In some embodiments, at least part of the covering or lining comprises a plurality of layers of amnion tissue. The method of making the biocompatible stent and its delivery and deployment are also discussed.

Abstract: Methods of allocating benefits received in response to generating energy within a community to a community interest. The methods include deploying energy generating equipment on property of a host community member and receiving a benefit associated with purchasing the energy generating equipment or generating energy with the energy generating equipment. The methods further include estimating a benefit rate according to an expected generation value, the expected generation value defining an amount of energy expected to be generated by the energy generating equipment at a later time. Moreover, the methods include distributing at least a portion of the benefit to the community interest, the portion of the benefit distributed to the community interest calculated based on the benefit rate.

Abstract: Methods of allocating benefits received in response to generating energy within communities to community interests, including deploying energy generating equipment on properties of host community members, delivering delivered portions of the energy generated by the energy generating equipment to host community members, receiving community members, or power grids, measuring the delivered portions of the energy to produce measurements, receiving benefits associated with purchasing the energy generating equipment or generating energy with the energy generating equipment, the benefits defining amounts calculated based on the measurements, distributing portions of the benefit to community interests. In some examples, a community portion of the energy may be donated to community interest organizations. In some examples, benefits may define government subsidies. In some examples, marketing materials may be delivered from non-profit entities.

Abstract: A stent scaffold combined with amniotic tissue provides for a biocompatible stent that has improved biocompatibility and hemocompatibility. The amnion tissue can be variously modified or unmodified form of amnion tissue such as non-cryo amnion tissue, solubilized amnion tissue, amnion tissue fabric, chemically modified amnion tissue, amnion tissue treated with radiation, amnion tissue treated with heat, or a combination thereof. Materials such as polymer, placental tissue, pericardium tissue, small intestine submucosa can be used in combination with the amnion tissue. The amnion tissue can be attached to the inside, the outside, both inside and outside, or complete encapsulation of the stent scaffold. In some embodiments, at least part of the covering or lining comprises a plurality of layers of amnion tissue. The method of making the biocompatible stent and its delivery and deployment are also discussed.

Abstract: A method of protecting a turbine compressor of a gas turbine engine that is part of an integrated gasification combined-cycle power generation system that includes an air separation unit that may include the steps of: (1) extracting an amount of compressed air that is compressed by the turbine compressor; (2) supplying the extracted amount of compressed air to the air separation unit; and (3) varying the amount of compressed air extracted from the turbine compressor based upon a desired compressor pressure ratio across the turbine compressor. The method further may include the step of supplying the air separation unit with a supply of compressed air from a main air compressor. The amount of compressed air supplied to the air separation unit by the main air compressor may be varied based upon the amount of compressed air extracted from the turbine compressor.

Abstract: A method of controlling a load of a gas turbine engine that is part of an integrated gasification combined-cycle power generation system, which includes an air separation unit, that includes the steps of: (1) extracting an amount of compressed air that is compressed by a turbine compressor; (2) supplying the extracted amount of compressed air to the air separation unit; and (3) varying the amount of compressed air extracted from the turbine compressor based upon a desired load for the gas turbine engine.

Abstract: The invention encompasses a transfection complex comprising a polypeptide comprising the contiguous 29 amino acids: 6G's, 2F's, 2L's, 1W, 4R's, 2E's, 2N's, 3K's, 1T, 1S, 1A, 1Y, 1M, 1C, and 1I, and having additional cationic residues to provide a net number of positive charges of equal to or greater than 8, and an isolated nucleic acid, and methods of transfecting cells using this transfection complex. The invention also includes a polypeptide having an amino acid composition including these 29 amino acids, as well as mixtures of polypeptides in which this polypeptide is present.

Abstract: The invention encompasses a transfection complex comprising a polypeptide comprising the contiguous 29 amino acids: 6G's, 2F's, 2L's, 1W, 4R's, 2E's, 2N's, 3K's, 1T, 1S, 1A, 1Y, 1M, 1C, and 1I, and having additional cationic residues to provide a net number of positive charges of equal to or greater than 8, and an isolated nucleic acid, and methods of transfecting cells using this transfection complex. The invention also includes a polypeptide having an amino acid composition including these 29 amino acids, as well as mixtures of polypeptides in which this polypeptide is present.